Investing in Vaccines for Developing Countries: How Public-Private Partnerships Can Confront Neglected Diseases
This commentary discusses the barrier of vaccine price on sustainable immunization programs in developing countries and offers examples of new mechanisms driven by public-private partnerships to overcome issues of affordability.
Author(s): Yaïch M
Visit website (English)
(Located at www.landesbioscience.com)
Yaich M. Investing in vaccines for developing countries: How public-private partnerships can confront neglected diseases. Human Vaccines. 2009;5(6).